Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul D Greig

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Hepatology (Baltimore, Md.)|May 15, 2016
The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation studyGonzalo Sapisochin, Nicolas Goldaracena, Jerome M Laurence, et al.
Transplantation Direct|October 14, 2017
Avoiding ICU Admission by Using a Fast-Track Protocol Is Safe in Selected Adult-to-Adult Live Donor Liver Transplant RecipientsJuan Echeverri, Nicolas Goldaracena, Akhil Kant Singh, et al.
Clinical Transplantation|June 28, 2018
Live donor liver transplantation with older donors: Increased long-term graft loss due to HCV recurrenceNicolas Goldaracena, Andrew S Barbas, Antonio Galante, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 8, 2017
Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control studyAloysious D Aravinthan, Andrew S Barbas, Adam C Doyle, et al.
Annals of Surgical Oncology|January 13, 2018
Liver Transplantation is Equally Effective as a Salvage Therapy for Patients with Hepatocellular Carcinoma Recurrence Following Radiofrequency Ablation or Liver Resection with Curative IntentHala Muaddi, David P Al-Adra, Rob Beecroft, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 27, 2005
Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trialEric M Yoshida, Paul J Marotta, Paul D Greig, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 25, 2016
Normothermic ex vivo liver perfusion using steen solution as perfusate for human liver transplantation: First North American resultsMarkus Selzner, Nicolas Goldaracena, Juan Echeverri, et al.
Transplantation Direct|June 17, 2017
Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto ExperienceAndrew S Barbas, Nicolas Goldaracena, Martin J Dib, et al.
Journal of the American College of Surgeons|April 27, 2016
Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional EvaluationJulie N Leal, Alexsander K Bressan, Neeta Vachharajani, et al.
Annals of Surgical Oncology|February 5, 2017
Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular CarcinomaAloysious D Aravinthan, Silvio G Bruni, Adam C Doyle, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Hepatology (Baltimore, Md.)|May 15, 2016
The extended Toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation studyGonzalo Sapisochin, Nicolas Goldaracena, Jerome M Laurence, et al.
Transplantation Direct|October 14, 2017
Avoiding ICU Admission by Using a Fast-Track Protocol Is Safe in Selected Adult-to-Adult Live Donor Liver Transplant RecipientsJuan Echeverri, Nicolas Goldaracena, Akhil Kant Singh, et al.
Clinical Transplantation|June 28, 2018
Live donor liver transplantation with older donors: Increased long-term graft loss due to HCV recurrenceNicolas Goldaracena, Andrew S Barbas, Antonio Galante, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 8, 2017
Characteristics of liver transplant candidates delisted following recompensation and predictors of such delisting in alcohol-related liver disease: a case-control studyAloysious D Aravinthan, Andrew S Barbas, Adam C Doyle, et al.
Annals of Surgical Oncology|January 13, 2018
Liver Transplantation is Equally Effective as a Salvage Therapy for Patients with Hepatocellular Carcinoma Recurrence Following Radiofrequency Ablation or Liver Resection with Curative IntentHala Muaddi, David P Al-Adra, Rob Beecroft, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|August 27, 2005
Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs. a standard-dose tacrolimus and mycophenolate mofetil regimen: a multicenter randomized clinical trialEric M Yoshida, Paul J Marotta, Paul D Greig, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 25, 2016
Normothermic ex vivo liver perfusion using steen solution as perfusate for human liver transplantation: First North American resultsMarkus Selzner, Nicolas Goldaracena, Juan Echeverri, et al.
Transplantation Direct|June 17, 2017
Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto ExperienceAndrew S Barbas, Nicolas Goldaracena, Martin J Dib, et al.
Journal of the American College of Surgeons|April 27, 2016
Time-to-Surgery and Survival Outcomes in Resectable Colorectal Liver Metastases: A Multi-Institutional EvaluationJulie N Leal, Alexsander K Bressan, Neeta Vachharajani, et al.
Annals of Surgical Oncology|February 5, 2017
Liver Transplantation is a Preferable Alternative to Palliative Therapy for Selected Patients with Advanced Hepatocellular CarcinomaAloysious D Aravinthan, Silvio G Bruni, Adam C Doyle, et al.
Pageof 10